Clinical Research Studies

This study is looking to enroll patients or their children who have Dravet Syndrome or other conditions. This is a multi-collaborative study between NYU Medical Comprehensive Epilepsy Center, The Epilepsy Foundation, Pfizer, to study pluripotent stem cells to develop a personalized medicine platform (medicine tailored to specific people) for epilepsy, more specifically, for Dravet Syndrome and other conditions. Pluripotent stem cells are cells that can arise into many different kinds of cells. This study will also look at genetic mutations (changes) associated with Dravet Syndrome and other conditions to evaluate medication effect and compare to participants' medical history. Genes determine things about people like hair and eye color, but also indicate risk for disease and responsiveness to treatment.